Aptevo Therapeutics Inc.(APVO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

APVO Aptevo Therapeutics Inc.

已收盘 12-22 16:00:00 EST

1.10

+0.03

+2.80%

盘后1.07

-0.03-2.73%

19:58 EST

最高1.11	最低1.06	成交量47.22万
今开1.07	昨收1.07	日振幅5.14%
总市值1,854万	流通市值1,486万	总股本1,685万
成交额51.45万	换手率3.50%	流通股本1,351万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"APVO","market":"US","secType":"STK","nameCN":"Aptevo Therapeutics Inc.","latestPrice":1.1,"timestamp":1766437200000,"preClose":1.07,"halted":0,"volume":472227,"hourTrading":{"tag":"盘后","latestPrice":1.07,"preClose":1.1,"latestTime":"19:58 EST","volume":12403,"amount":13305.8975,"timestamp":1766451494519},"delay":0,"floatShares":13509000,"shares":16850494,"eps":-110.77861,"marketStatus":"已收盘","change":0.03,"latestTime":"12-22 16:00:00 EST","open":1.07,"high":1.11,"low":1.055,"amount":514485.7914441,"amplitude":0.051402,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-110.77861,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1766480400000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.07,"preHourTrading":{"tag":"盘前","latestPrice":1.08,"preClose":1.07,"latestTime":"09:29 EST","volume":26962,"amount":28921.706008,"timestamp":1766413799561},"postHourTrading":{"tag":"盘后","latestPrice":1.07,"preClose":1.1,"latestTime":"19:58 EST","volume":12403,"amount":13305.8975,"timestamp":1766451494519},"volumeRatio":0.643452},"requestUrl":"/m/hq/s/APVO","defaultTab":"news","newsList":[{"id":"2552397171","title":"Aptevo Therapeutics Inc.7月16日成交额为59.22万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552397171","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552397171?lang=zh_cn&edition=full","pubTime":"2025-07-17 09:17","pubTimestamp":1752715042,"startTime":"0","endTime":"0","summary":"美东时间2025年7月16日，Aptevo Therapeutics Inc.成交额为59.22万美元，成交额较昨日增加29.77%，当日成交量为19.96万股。Aptevo Therapeutics Inc.于2025年7月16日涨3.77%，报3.03美元，该股过去5个交易日跌0.33%，年初至今跌96.48%，过去60日跌82.42%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-16|59.22万|29.77%|19.96万|#|2025-07-15|45.64万|-21.37%|15.64万|#|2025-07-14|58.04万|50.85%|19.66万|#|2025-07-11|38.48万|-5.94%|12.94万|#|2025-07-10|40.91万|-40.92%|13.59万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717091733a44fbf00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717091733a44fbf00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APVO","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"2546525088","title":"Aptevo Therapeutics Inc.6月24日成交额为433.61万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546525088","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546525088?lang=zh_cn&edition=full","pubTime":"2025-06-25 09:16","pubTimestamp":1750814213,"startTime":"0","endTime":"0","summary":"美东时间2025年6月24日，Aptevo Therapeutics Inc.成交额为433.61万美元，成交额较昨日减少5.77%，当日成交量为119.35万股。Aptevo Therapeutics Inc.于2025年6月24日涨6.46%，报3.46美元，该股过去5个交易日跌5.46%，年初至今跌95.99%，过去60日跌86.16%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-24|433.61万|-5.77%|119.35万|#|2025-06-23|460.17万|-65.75%|128.68万|#|2025-06-20|1343.48万|-98.62%|322.58万|#|2025-06-18|9.70亿|107168.47%|1.24亿|#|2025-06-17|90.45万|60.64%|26.88万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625091706a71c1047&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625091706a71c1047&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APVO","BK4007","LENZ","BK4139","BK4539"],"gpt_icon":1},{"id":"2544909909","title":"美股异动 | Mipletamig疗法在白血病患者中达到85%缓解率 Aptevo Therapeutics(APVO.US)飙升超130%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544909909","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544909909?lang=zh_cn&edition=full","pubTime":"2025-06-18 23:41","pubTimestamp":1750261300,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周三，Aptevo Therapeutics(APVO.US)飙升超130%，报6.52美元。消息面上，该公司表示，其mipletamig组合疗法在前线急性髓性白血病患者中达到85%的缓解率。根据Aptevo所述的1b/2期Rainer试验结果，mipletamig的治疗方法在不适合化疗的患者中显示出强大的疗效和安全性。该试验的第3组正在以测试的最高剂量水平接近完全入组，公司的乐观态度使其对mipletamig的潜力充满信心。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1306994.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LENZ","APVO","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"2544987530","title":"Aptevo Therapeutics Inc.6月16日成交额为56.31万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544987530","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544987530?lang=zh_cn&edition=full","pubTime":"2025-06-17 09:17","pubTimestamp":1750123022,"startTime":"0","endTime":"0","summary":"美东时间2025年6月16日，Aptevo Therapeutics Inc.成交额为56.31万美元，成交额较昨日减少15.62%，当日成交量为14.85万股。Aptevo Therapeutics Inc.于2025年6月16日跌16.63%，报3.66美元，该股过去5个交易日跌21.79%，年初至今跌95.75%，过去60日跌92.59%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-16|56.31万|-15.62%|14.85万|#|2025-06-13|66.73万|481.09%|14.81万|#|2025-06-12|11.48万|-68.74%|2.48万|#|2025-06-11|36.74万|214.73%|7.76万|#|2025-06-10|11.67万|-69.70%|2.51万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617091713a4ad2b52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617091713a4ad2b52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","BK4539","APVO"],"gpt_icon":0},{"id":"2543651367","title":"Aptevo Therapeutics Inc.6月13日成交额为66.73万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543651367","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543651367?lang=zh_cn&edition=full","pubTime":"2025-06-14 09:17","pubTimestamp":1749863821,"startTime":"0","endTime":"0","summary":"美东时间2025年6月13日，Aptevo Therapeutics Inc.成交额为66.73万美元，成交额较昨日增加481.09%，当日成交量为14.81万股。Aptevo Therapeutics Inc.于2025年6月13日跌8.16%，报4.39美元，该股过去5个交易日跌11.31%，年初至今跌94.91%，过去60日跌91.65%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-13|66.73万|481.09%|14.81万|#|2025-06-12|11.48万|-68.74%|2.48万|#|2025-06-11|36.74万|214.73%|7.76万|#|2025-06-10|11.67万|-69.70%|2.51万|#|2025-06-09|38.53万|29.56%|7.97万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614091708a4a87407&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614091708a4a87407&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","LENZ","BK4139","APVO"],"gpt_icon":0},{"id":"2517197972","title":"Aptevo Therapeutics Inc.盘中异动 下午盘股价大跌6.68%报2.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517197972","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517197972?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:28","pubTimestamp":1741289314,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时28分，Aptevo Therapeutics Inc.股票出现波动，股价急速跳水6.68%。截至发稿，该股报2.59美元/股，成交量2.5087万股，换手率1.72%，振幅5.25%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.72%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307032834a262d671&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307032834a262d671&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","APVO"],"gpt_icon":0},{"id":"2517983456","title":"Aptevo Therapeutics Inc.盘中异动 下午盘快速下挫5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517983456","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517983456?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:57","pubTimestamp":1741118267,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日03时57分，Aptevo Therapeutics Inc.股票出现异动，股价急速跳水5.88%。截至发稿，该股报2.91美元/股，成交量2.9196万股，换手率2.00%，振幅5.83%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305035747a25f5f02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305035747a25f5f02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APVO","BK4139"],"gpt_icon":0},{"id":"2516655136","title":"Aptevo Therapeutics Inc.盘中异动 临近午盘快速下跌8.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516655136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516655136?lang=zh_cn&edition=full","pubTime":"2025-03-04 00:39","pubTimestamp":1741019963,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日00时39分，Aptevo Therapeutics Inc.股票出现异动，股价急速跳水8.38%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为3922.52%、173.32%、141.87%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、94.90%、70.53%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304003923abe65b30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304003923abe65b30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","APVO"],"gpt_icon":0},{"id":"2514937376","title":"Aptevo Therapeutics Inc.盘中异动 快速拉升5.85%报3.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514937376","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514937376?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:41","pubTimestamp":1740757316,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时41分，Aptevo Therapeutics Inc.股票出现异动，股价快速拉升5.85%。截至发稿，该股报3.80美元/股，成交量2.7148万股，换手率1.86%，振幅6.13%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502282341579896898f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502282341579896898f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APVO","LENZ"],"gpt_icon":0},{"id":"2514738573","title":"Aptevo Therapeutics Inc.盘中异动 股价大涨6.38%报3.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514738573","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514738573?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:37","pubTimestamp":1740667074,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时37分，Aptevo Therapeutics Inc.股票出现波动，股价大幅上涨6.38%。截至发稿，该股报3.50美元/股，成交量7331股，换手率0.50%，振幅0.91%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.85%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223754a2567bc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223754a2567bc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APVO","LENZ","BK4139"],"gpt_icon":0},{"id":"2514856074","title":"Aptevo Therapeutics Inc.盘中异动 早盘快速上涨5.54%报3.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514856074?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:34","pubTimestamp":1740580444,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时34分，Aptevo Therapeutics Inc.股票出现异动，股价快速上涨5.54%。截至发稿，该股报3.24美元/股，成交量2465股，换手率0.17%，振幅0.00%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223404a254f72d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223404a254f72d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","APVO"],"gpt_icon":0},{"id":"2514013592","title":"Aptevo Therapeutics Inc.盘中异动 早盘大幅上涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514013592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514013592?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:44","pubTimestamp":1740494665,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时44分，Aptevo Therapeutics Inc.股票出现波动，股价快速拉升5.14%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为855.06%、620.78%、532.76%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Gt Biopharma, Inc.，振幅分别为100.27%、46.65%、33.50%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家处于临床研究开发阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224425962ff596&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224425962ff596&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","APVO"],"gpt_icon":0},{"id":"2513720430","title":"Aptevo Therapeutics Inc.盘中异动 早盘股价大跌5.48%报3.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720430","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513720430?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:08","pubTimestamp":1740409697,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时08分，Aptevo Therapeutics Inc.股票出现异动，股价大幅下挫5.48%。截至发稿，该股报3.28美元/股，成交量1.106万股，换手率0.76%，振幅4.32%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家处于临床研究开发阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230818962ea200&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230818962ea200&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APVO","BK4139"],"gpt_icon":0},{"id":"2512216504","title":"Aptevo Therapeutics Inc.盘中异动 早盘股价大涨9.58%报3.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512216504","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512216504?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:31","pubTimestamp":1739889110,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时31分，Aptevo Therapeutics Inc.股票出现异动，股价大幅拉升9.58%。截至发稿，该股报3.66美元/股，成交量1.2623万股，换手率0.87%，振幅0.00%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家处于临床研究开发阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182231509889fc91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182231509889fc91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APVO","LENZ","BK4139"],"gpt_icon":0},{"id":"2511998796","title":"Aptevo Therapeutics Inc.盘中异动 股价大涨8.41%报3.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511998796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511998796?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:32","pubTimestamp":1739543528,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时32分，Aptevo Therapeutics Inc.股票出现波动，股价快速上涨8.41%。截至发稿，该股报3.95美元/股，成交量1.1322万股，换手率0.78%，振幅0.10%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家处于临床研究开发阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223208abcf0691&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223208abcf0691&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","APVO"],"gpt_icon":0},{"id":"1192603528","title":"Aptevo Therapeutics 2024年每股收益为负$87.38，现金持有量为870万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1192603528","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192603528?lang=zh_cn&edition=full","pubTime":"2025-02-14 21:12","pubTimestamp":1739538738,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics(LENZ) 2024年每股收益为负$87.38，现金持有量为870万美元以上内容来自Benzinga Earnings专栏，原文如下：Aptevo $Therapeutics(LENZ)$ 22024 EPS $(87.38), Cash Position $8.7M","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Aptevo Therapeutics 2024年每股收益为负$87.38，现金持有量为870万美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APVO"],"gpt_icon":0},{"id":"2511522033","title":"Aptevo Therapeutics Inc.盘中异动 早盘股价大跌5.07%报3.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511522033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511522033?lang=zh_cn&edition=full","pubTime":"2025-02-14 00:23","pubTimestamp":1739463835,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日00时23分，Aptevo Therapeutics Inc.股票出现波动，股价大幅跳水5.07%。截至发稿，该股报3.56美元/股，成交量1.0536万股，换手率0.72%，振幅3.84%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.88%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家处于临床研究开发阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021400235698844237&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021400235698844237&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APVO","LENZ"],"gpt_icon":0},{"id":"2509177357","title":"Aptevo Therapeutics Inc.盘中异动 大幅下挫9.28%报3.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509177357","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509177357?lang=zh_cn&edition=full","pubTime":"2025-02-08 03:36","pubTimestamp":1738956965,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日03时36分，Aptevo Therapeutics Inc.股票出现波动，股价快速下挫9.28%。截至发稿，该股报3.91美元/股，成交量7016股，换手率0.48%，振幅4.41%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.63%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家处于临床研究开发阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208033605961b6b68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208033605961b6b68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","APVO"],"gpt_icon":0},{"id":"2509676467","title":"Aptevo Therapeutics Inc.盘中异动 下午盘大幅下跌6.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509676467","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509676467?lang=zh_cn&edition=full","pubTime":"2025-02-05 02:03","pubTimestamp":1738692206,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日02时03分，Aptevo Therapeutics Inc.股票出现波动，股价急速跳水6.90%。截至发稿，该股报4.05美元/股，成交量1.7865万股，换手率1.22%，振幅3.90%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.26%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家处于临床研究开发阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205020326a2395052&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205020326a2395052&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","APVO"],"gpt_icon":0},{"id":"2507535650","title":"Aptevo Therapeutics Inc.盘中异动 大幅下挫5.08%报4.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507535650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507535650?lang=zh_cn&edition=full","pubTime":"2025-01-30 04:01","pubTimestamp":1738180915,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日04时01分，Aptevo Therapeutics Inc.股票出现异动，股价快速跳水5.08%。截至发稿，该股报4.30美元/股，成交量2.2713万股，换手率1.56%，振幅4.71%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.39%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家处于临床研究开发阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130040155abbc930d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130040155abbc930d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","APVO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aptevotherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0531},{"period":"1month","weight":-0.123},{"period":"3month","weight":-0.392},{"period":"6month","weight":-0.7434},{"period":"1year","weight":-0.9882},{"period":"ytd","weight":-0.9876}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1452},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1613}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aptevo Therapeutics Inc.于2016年2月在特拉华州注册成立。该公司是一家临床阶段的研发生物技术公司，专注于开发用于治疗不同形式癌症的新型免疫疗法候选者。该公司开发了两种多功能平台技术，用于合理设计精准免疫调节药物。该公司的主要临床候选药物APVO436和ALG.APV-527以及临床前候选药物APVO603和APVO711是使用ADAPTIR模块蛋白技术平台开发的。该公司的临床前候选药物APVO442是利用ADAPTIR-FLEX模块蛋白技术平台开发的。该公司的ADAPTIR和ADAPTIR-FLEX平台旨在产生能够增强人体免疫系统对抗癌细胞的单特异性、双特异性和多特异性候选抗体。","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":-0.073504},{"month":2,"riseRate":0.222222,"avgChangeRate":-0.064327},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.20989},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.15126},{"month":5,"riseRate":0.555556,"avgChangeRate":-0.026729},{"month":6,"riseRate":0.222222,"avgChangeRate":-0.08688},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.041449},{"month":8,"riseRate":0.111111,"avgChangeRate":-0.166485},{"month":9,"riseRate":0.1,"avgChangeRate":-0.074626},{"month":10,"riseRate":0.3,"avgChangeRate":-0.002789},{"month":11,"riseRate":0.5,"avgChangeRate":0.481281},{"month":12,"riseRate":0.3,"avgChangeRate":-0.121705}],"exchange":"NASDAQ","name":"Aptevo Therapeutics Inc.","nameEN":"Aptevo Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aptevo Therapeutics Inc.(APVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aptevo Therapeutics Inc.(APVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aptevo Therapeutics Inc.,APVO,Aptevo Therapeutics Inc.股票,Aptevo Therapeutics Inc.股票老虎,Aptevo Therapeutics Inc.股票老虎国际,Aptevo Therapeutics Inc.行情,Aptevo Therapeutics Inc.股票行情,Aptevo Therapeutics Inc.股价,Aptevo Therapeutics Inc.股市,Aptevo Therapeutics Inc.股票价格,Aptevo Therapeutics Inc.股票交易,Aptevo Therapeutics Inc.股票购买,Aptevo Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aptevo Therapeutics Inc.(APVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aptevo Therapeutics Inc.(APVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}